Irinotecan and Capecitabine in Treating Women With Advanced Breast Cancer

NCT00083148 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: capecitabine
DRUG: irinotecan hydrochloride

Sponsor

Roswell Park Cancer Institute